Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2413
http://purl.obolibrary.org/obo/NCIT_C2413
|
|---|---|
| Preferred Name | Recombinant Leukocyte Interleukin |
| Definitions |
A cocktail preparation of synthetic interleukin (IL) -1, IL-2, IL-6, tumor necrosis factor (TNF)-alpha, interferon gamma and other cytokines that are chemically identical to or similar to signaling molecules secreted by leukocyte cells. Leukocyte interleukins are essential in many immune responses, such as antibodies production, modulating secretion of other cytokines, and activation of bone marrow stem cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cocktail preparation of synthetic interleukin (IL) -1, IL-2, IL-6, tumor necrosis factor (TNF)-alpha, interferon gamma and other cytokines that are chemically identical to or similar to signaling molecules secreted by leukocyte cells. Leukocyte interleukins are essential in many immune responses, such as antibodies production, modulating secretion of other cytokines, and activation of bone marrow stem cells. |
|---|---|
| prefLabel | Recombinant Leukocyte Interleukin
|
| label | Recombinant Leukocyte Interleukin
|
| PDQ_Closed_Trial_Search_ID | 42580
|
| code | C2413
|
| prefixIRI | NCIT:C2413
|
| in_subset | |
| Preferred_Name | Recombinant Leukocyte Interleukin
|
| Maps_To | Recombinant Leukocyte Interleukin
|
| NCI_Drug_Dictionary_ID | 42580
|
| Legacy Concept Name | Therapeutic_Leukocyte_Interleukin
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42580
|
| Accepted_Therapeutic_Use_For | neoadjuvant therapy for patients with squamous cell carcinoma of the head and neck
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0392999
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |